BRPI0414069A8 - Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana - Google Patents

Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana

Info

Publication number
BRPI0414069A8
BRPI0414069A8 BRPI0414069A BRPI0414069A BRPI0414069A8 BR PI0414069 A8 BRPI0414069 A8 BR PI0414069A8 BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A8 BRPI0414069 A8 BR PI0414069A8
Authority
BR
Brazil
Prior art keywords
bacteria
safranin
treatment area
photodynamic
therapeutic composition
Prior art date
Application number
BRPI0414069A
Other languages
English (en)
Inventor
Albrecht Volker
Gitter Burkhard
Original Assignee
Ceramoptec Ind Inc
Biolitec Pharma Marketing Ltd
Biolitec Unternehmensbeteiligungs Ii Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Ind Inc, Biolitec Pharma Marketing Ltd, Biolitec Unternehmensbeteiligungs Ii Ag filed Critical Ceramoptec Ind Inc
Publication of BRPI0414069A publication Critical patent/BRPI0414069A/pt
Publication of BRPI0414069A8 publication Critical patent/BRPI0414069A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Método de destruição de bactéria em área de tratamento do paciente e respectiva composi-ção terapêutica fotodinâmica antimicrobiana Inativação Fotodinâmica de Staphylococcus aureus DSM1104 por Safranina O É revelado um método e composição para destruição de micróbios, especialmente bactéri-as, no corpo, utilizando Safranina O em conjunção com radiação eletromagnética. Num méto-do preferido, uma composição compreendendo Safranina O é introduzida numa área de tra-tamento. Após ter passado um período de tempo suficiente, é aplicada radiação de um com-primento de onda adequado na área para ativar a Safranina O e, por uma reação fotodi-nâmica, destruir as bactérias. A radiação preferida tem um comprimento de onda em torno de 530 nm. Este método é efetivo para a destruição tanto de bactérias Gram-positivas como de Gram-negativas e é particularmente efetivo em áreas onde estão presentes meios com-plexos, tais como soro sangüíneo, sangue ou saliva.
BRPI0414069A 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana BRPI0414069A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49984703P 2003-09-02 2003-09-02
US10/860,296 US20050049228A1 (en) 2003-09-02 2004-06-03 Antimicrobial photodynamic therapy compound and method of use
PCT/US2004/028180 WO2005021094A2 (en) 2003-09-02 2004-08-30 Antimicrobial photodynamic therapy compound

Publications (2)

Publication Number Publication Date
BRPI0414069A BRPI0414069A (pt) 2006-10-24
BRPI0414069A8 true BRPI0414069A8 (pt) 2016-10-11

Family

ID=34221799

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414069A BRPI0414069A8 (pt) 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana

Country Status (6)

Country Link
US (1) US20050049228A1 (pt)
EP (1) EP1701726B1 (pt)
JP (1) JP4828423B2 (pt)
BR (1) BRPI0414069A8 (pt)
RU (1) RU2376991C2 (pt)
WO (1) WO2005021094A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
CN103767886B (zh) 2005-11-09 2018-04-24 科洛斯科技公司 使牙齿增白的组合物及方法
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
US8906334B2 (en) 2007-05-14 2014-12-09 Invista North America S.A R.L. High efficiency reactor and process
KR20180023070A (ko) 2008-11-07 2018-03-06 클록스 테크놀로지스 인크. 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
WO2010141564A2 (en) * 2009-06-02 2010-12-09 Ceramoptec Industries, Inc. A novel method for microbial depletion in human blood and blood products using antimicrobial photodynamic therapy
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
JP5945228B2 (ja) * 2010-01-19 2016-07-05 バイオリテック ファーマ マーケティング リミテッド 増強された抗菌ｐｄｔ
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
BR112015005593B1 (pt) 2012-09-14 2019-09-24 Valeant Pharmaceuticals International, Inc. Método para branqueamento de dentes
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
US10232066B2 (en) 2016-10-31 2019-03-19 Hubbell Incorporated High intensity narrow spectrum light indicator systems
US11272594B2 (en) 2016-10-31 2022-03-08 Hubbell Incorporated Multi-array lighting system for providing high intensity narrow spectrum light
EP3703763A4 (en) 2017-10-30 2021-12-08 Hubbell Incorporated ANTIMICROBIAL BACKLIT DEVICE
US11590248B2 (en) 2017-10-30 2023-02-28 Hubbell Lighting, Inc. Pulsing high intensity narrow spectrum light
RU2700407C1 (ru) * 2018-07-23 2019-09-16 Михаил Тимофеевич Александров Способ лечения опухолевых и воспалительных заболеваний с применением фотодинамической терапии
US11388789B2 (en) 2019-03-18 2022-07-12 Hubbell Lighting, Inc. Method for controlling operation of a lighting system having high intensity narrow spectrum light sources
EP4221827A4 (en) * 2020-09-30 2024-04-17 Jernigan, David, A. Method of manipulating phages within the body to attack infectious target cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798112A (en) * 1994-12-09 1998-08-25 The United States Of America As Represented By The Secretary Of Agriculture Phototoxic insecticidal composition and method for controlling insect populations
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
US5990199A (en) * 1995-04-19 1999-11-23 North American Science Associates, Inc. Indicator ink compositions
US6084005A (en) * 1997-02-24 2000-07-04 Kuraray Co., Ltd. Antimicrobial caries-detecting composition
US8187278B2 (en) * 1998-08-25 2012-05-29 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and benzalkonium chloride
US6506791B2 (en) * 2000-08-09 2003-01-14 Jacksonville State University Method of treatment of protozoan infections in fish
US6887862B2 (en) * 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
JP2005502618A (ja) * 2001-06-04 2005-01-27 ザ・ジェネラル・ホスピタル・コーポレイション 光力学的化合物を用いて脆弱なプラークを検出および治療する方法
US6558653B2 (en) * 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
WO2005034855A2 (en) * 2003-09-05 2005-04-21 The General Hospital Corporation Photodynamic inactivation of bacterial spores

Also Published As

Publication number Publication date
US20050049228A1 (en) 2005-03-03
RU2006110554A (ru) 2006-08-10
EP1701726A4 (en) 2007-01-03
JP2007503917A (ja) 2007-03-01
JP4828423B2 (ja) 2011-11-30
RU2376991C2 (ru) 2009-12-27
BRPI0414069A (pt) 2006-10-24
WO2005021094A3 (en) 2005-04-28
WO2005021094A2 (en) 2005-03-10
EP1701726B1 (en) 2019-01-23
EP1701726A2 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
BRPI0414069A (pt) método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana
Khan et al. Challenges of antibiotic resistance biofilms and potential combating strategies: a review
Narita et al. Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds
Kramer et al. Cold physical plasmas in the field of hygiene—relevance, significance, and future applications
Vassena et al. Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material
Gomes-Filho et al. Evaluation of photodynamic therapy on fibroblast viability and cytokine production
Caccianiga et al. Clinical, radiographic and microbiological evaluation of high level laser therapy, a new photodynamic therapy protocol, in peri‐implantitis treatment; a pilot experience
EP3003375B1 (en) Method of applying a composition and pharmaceutical composition with a regimen of administering it
Ribeiro et al. Photodynamic inactivation of microorganisms present on complete dentures. A clinical investigation: Photodynamic disinfection of complete dentures
Alshehri The role of lasers in the treatment of peri-implant diseases: A review
US20130142856A1 (en) Compositions comprising a germinant and an antimicrobial agent
WO2004024080A3 (en) Treatment of periodontal disease with photosensitizers
Misischia et al. Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro
Huang et al. Enhancing osteoblast functions on biofilm-contaminated titanium alloy by concentration-dependent use of methylene blue-mediated antimicrobial photodynamic therapy
CN118973622A (zh) 紫外线照射装置及紫外线照射方法
Mohd Masri et al. Sterilisation of Lucilia cuprina Wiedemann maggots used in therapy of intractable wounds
Shukla et al. Association and contribution of dentistry in creating and sharing the burden of antibiotic-resistant microbial world
Migliario et al. In vitro toxicity of photodynamic antimicrobial chemotherapy on human keratinocytes proliferation
Wainwright Maggot therapy—a backwater in the fight against bacterial infection
Sommer Antiinfectives and low-level light: a new chapter in photomedicine
Kocisova et al. First non-conventional veterinary treatment of skin infections with blowfly larvae (Calliphoridae) in Slovakia
Mohammad Zaman et al. Photodynamic inactivation of bacterial biofilms on absorbable collagen membranes using indocyanine green in aqueous and hydrogen peroxide solutions
Ozmen et al. Effects of repeated ultraviolet-C radiation on tissues: A Guinea pig model study
Ball et al. Antimicrobial activity of CO2 and Er: YAG lasers against Staphylococcus aureus and Escherichia coli

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BIOLITEC PHARMA MARKETING LTD. (MY)

B25A Requested transfer of rights approved

Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time